Russell Investments Group Ltd. cut its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 11.3% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 9,132 shares of the company’s stock after selling 1,160 shares during the quarter. Russell Investments Group Ltd.’s holdings in Acadia Healthcare were worth $660,000 at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. lifted its position in Acadia Healthcare by 1.5% in the third quarter. Vanguard Group Inc. now owns 8,758,004 shares of the company’s stock worth $684,700,000 after buying an additional 131,959 shares during the last quarter. State Street Corp lifted its position in Acadia Healthcare by 2.4% in the third quarter. State Street Corp now owns 2,451,285 shares of the company’s stock worth $191,641,000 after buying an additional 58,451 shares during the last quarter. Fred Alger Management LLC lifted its position in Acadia Healthcare by 14.6% in the fourth quarter. Fred Alger Management LLC now owns 2,323,220 shares of the company’s stock worth $191,247,000 after buying an additional 296,704 shares during the last quarter. Durable Capital Partners LP lifted its position in Acadia Healthcare by 30.8% in the fourth quarter. Durable Capital Partners LP now owns 1,941,595 shares of the company’s stock worth $159,832,000 after buying an additional 457,687 shares during the last quarter. Finally, Invesco Ltd. lifted its position in Acadia Healthcare by 12.2% in the first quarter. Invesco Ltd. now owns 1,792,919 shares of the company’s stock worth $117,490,000 after buying an additional 194,879 shares during the last quarter.
Acadia Healthcare Stock Performance
ACHC stock opened at $77.50 on Friday. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.34 and a quick ratio of 1.34. The business has a 50-day moving average price of $76.58 and a 200 day moving average price of $73.92. The company has a market capitalization of $7.14 billion, a P/E ratio of 26.18, a PEG ratio of 1.94 and a beta of 1.32. Acadia Healthcare Company, Inc. has a 1-year low of $66.87 and a 1-year high of $89.85.
Analyst Upgrades and Downgrades
A number of analysts recently issued reports on the company. Royal Bank of Canada raised their price target on Acadia Healthcare from $93.00 to $99.00 and gave the stock an “outperform” rating in a research report on Monday, July 31st. StockNews.com began coverage on Acadia Healthcare in a research report on Thursday, August 17th. They set a “hold” rating for the company. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, Acadia Healthcare currently has a consensus rating of “Hold” and a consensus target price of $87.38.
Read Our Latest Report on ACHC
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. It offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, eating disorder facilities, and outpatient clinics.
Further Reading
- Five stocks we like better than Acadia Healthcare
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- MarketBeat Week in Review – 8/28 – 9/1
- Investing In Automotive Stocks
- 2 Stocks That Doubled EPS Estimates and Flashing Buy Signals
- How to Invest in Artificial Intelligence
- Toyota vs Tesla: The Tortoise And The Hare Race Has A New Meaning
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.